NATUERA AND BRC COMPLETE FIRST IMPORT OF CANNABIS-DERIVED THC FROM COLOMBIA INTO THE UNITED STATES
NATUERA AND BRC COMPLETE FIRST IMPORT OF CANNABIS-DERIVED THC FROM COLOMBIA INTO THE UNITED STATES This is the first export-import of high-THC cannabis derivative products from Colombia to the United States conducted in compliance with applicable laws. The shipment, sent from NatuEra’s fully licensed, GMP-designed facility, located outside of Bogotá, was imported under a DEA permit by BRC for R&D purposes. March 30, 2021 – NatuEra S.à.r.l. (“NatuEra”), a joint venture between Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”) and an affiliate of Agroidea, and Biopharmaceutical Research Company (“BRC”), are pleased to announce the first successful shipment of cannabis-derived high-THC extract from Colombia to the United States, in compliance with applicable laws. This shipment of THC will be used for scientific research and analysis related to cannabis composition and safety, aimed at informing the ongoing policy discussions surrounding the advancement of a responsible, science-based framework for federal cannabis…